Ameriprise
ALBO

Ameriprise’s Albireo Pharma Inc ALBO Stock Holding History

Ameriprise’s Portfolio ALBO Stock Details ALBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-13,361
Closed -$471K – 3995
2021
Q1 		$471K Sell
13,361
-17,893
-57% -$661K ﹤0.01% 3434
2020
Q4 		$1.17M Buy
+31,254
New +$1.14M ﹤0.01% 3008
2016
Q3 		– Sell
-410
Closed -$4K – 3854
2016
Q2 		$4K Sell
410
-17
-4% -$187 ﹤0.01% 3751
2016
Q1 		$4K Hold
427
– – ﹤0.01% 3738
2015
Q4 		$4K Sell
427
-73
-15% -$755 ﹤0.01% 3861
2015
Q3 		$7K Sell
500
-67
-12% -$1.69K ﹤0.01% 3835
2015
Q2 		$18K Sell
567
-3,487
-86% -$117K ﹤0.01% 3989
2015
Q1 		$145K Buy
4,054
+3,153
+350% +$133K ﹤0.01% 3643
2014
Q4 		$36K Buy
901
+328
+57% +$14.4K ﹤0.01% 3642
2014
Q3 		$29K Buy
573
+448
+358% +$25.8K ﹤0.01% 4286
2014
Q2 		$8K Buy
+125
New +$8.69K ﹤0.01% 4781

Other funds holding ALBO

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

Ameriprise's ALBO Position: Q2 2021 in Review

Ameriprise sold out of Albireo Pharma Inc (ALBO) in Q2 2021, closing a stake of 13,361 shares — an estimated $471K sold.

Ameriprise first reported a position in ALBO in Q2 2014 and held it in 11 quarters. The position peaked at $1.17M in Q4 2020. 99 funds tracked by Wall St. Rank hold ALBO as of Q2 2021.

  • Ameriprise reported no remaining Albireo Pharma Inc position as of Q2 2021 after selling out during the quarter.
  • Ameriprise sold 13,361 Albireo Pharma Inc shares in Q2 2021, an estimated $471K.
  • Ameriprise first reported a position in Albireo Pharma Inc in Q2 2014 and held it in 11 quarters.
  • Ameriprise's Albireo Pharma Inc position peaked at $1.17M in Q4 2020.
  • 99 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q2 2021.

Based on Ameriprise's 13F filing for Q2 2021, filed 16 Aug 2021.